SCHEMBL4311615

SCHEMBL4311615

O=C(Nc1cccnc1)c1ccccc1C=Cc1n[nH]c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
HPGD P15428 1/20 0.51
KMT2A Q03164 1/20 0.51
CYP11B2 P19099 2/20 0.50
HSD17B10 Q99714 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
TSHR P16473 1/20 0.47
KDR P35968 3/20 0.46
IDO1 P14902 1/20 0.46
MAPK1 P28482 1/20 0.46
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
FLT3 P36888 1/20 0.45
CCNA1 P78396 1/20 0.45
NAMPT P43490 3/20 0.45
HTT P42858 1/20 0.45
WNT1 P04628 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4311607 1.00 ALDH1A1 (0.51) ALDH1A1KDM4EMEN1HPGDKMT2A
SCHEMBL4308050 0.89 FLT3 (0.58) KDM4ENPC1KDRIDO1CCNA2
SCHEMBL4308053 0.89 FLT3 (0.58) KDM4ENPC1KDRIDO1CCNA2
SCHEMBL4307898 0.80 KDR (0.49) ALDH1A1KDM4EKDRHTT
SCHEMBL4307902 0.80 KDR (0.49) ALDH1A1KDM4EKDRHTT
SCHEMBL28291152 0.78 FLT3 (0.74) IDO1CCNA2CDK2FLT3CCNA1
SCHEMBL4313388 0.77 CYP1A2 (0.52) ALDH1A1KDM4EMEN1HPGDKMT2A
SCHEMBL4313399 0.77 CYP1A2 (0.52) ALDH1A1KDM4EMEN1HPGDKMT2A
SCHEMBL4329156 0.77 KDM4E (0.40) KDM4EKDRCCNA2CDK2FLT3
SCHEMBL4329167 0.77 KDM4E (0.40) KDM4EKDRCCNA2CDK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101111483-B IGF-1R inhibitors KYOWA HAKKO KIRIN CO.,LTD. (JP) 2011-12-14 CN disclosed
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
CN-101111483-A IGF-1R inhibitors KYOWA HAKKO KOGYO KK (JP) 2008-01-23 CN disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 ALDH1A1 1250/4885KDM4E 1251/4885MEN1 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.